Drug Shortage Report for PREVACID
| Report ID | 105798 |
| Drug Identification Number | 02165511 |
| Brand name | PREVACID |
| Common or Proper name | LANSOPRAZOLE |
| Company Name | TAKEDA PHARMACEUTICALS AMERICA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | LANSOPRAZOLE |
| Strength(s) | 30MG |
| Dosage form(s) | CAPSULE (DELAYED RELEASE) |
| Route of administration | ORAL |
| Packaging size | 30 |
| ATC code | A02BC |
| ATC description | DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD) |
| Reason for shortage | Delay in shipping of the drug. |
| Anticipated start date | 2020-03-01 |
| Actual start date | |
| Estimated end date | 2020-03-05 |
| Actual end date | 2020-02-27 |
| Shortage status | Avoided shortage |
| Updated date | 2020-02-27 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 500 KENDALL STREET CAMBRIDGE, MASSACHUSETTS UNITED STATES 02142 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v3 | 2020-02-27 | English | Compare |
| v2 | 2020-02-12 | French | Compare |
| v1 | 2020-02-12 | English | Compare |
Showing 1 to 3 of 3